Morepen Labs incorporates new step-down subsidiary in mainland Dubai
Gurugram: Morepen Laboratories Limited has announced the incorporation of a new step-down subsidiary, Morepen Medical Equipment Trading L.L.C, in mainland Dubai, United Arab Emirates (UAE).
The newly incorporated entity is a wholly owned subsidiary of Morepen Medipath Limited (formerly Morepen Medtech Limited) and aims to focus on the sales and marketing of medical devices’ products in the international market including Dubai, U.A.E., and others.
Morepen Labs indirectly holds a 60% of the shares in the Dubai-based company through Morepen Medipath.
Morepen Medipath Limited has subscribed
100 shares, of AED 1000 each, for an aggregate
amount of AED 100000.
The denomination of share has been changed from
AED 10 each to AED 1000
each, however, the
total capital, being AED 100000 remain unchanged.
The new subsidiary, incorporated on July 22, 2025, will operate in the medical devices segment.
In June, Medical Dialogues reported the incorporation of MOREPEN LABS – FZCO, a wholly owned subsidiary of Morepen Labs in Dubai.
Read also: Morepen Labs incorporates wholly owned subsidiary in Dubai
In April, the company also announced an expansion of its salesforce, with plans to onboard over 1,000 professionals over the next three years. Of these, 200 new team members are expected to join in FY26. The recruitment drive is part of Morepen’s strategy to strengthen engagement with doctors, pharmacies, patients, and healthcare professionals across India.
Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.
Read also: Morepen Labs plans to employ over 1000 professionals
